The scientist of our country finds that resists hepatitis B and virus to infect the new mechanism

The scientist of our country finds that resists hepatitis B and virus to infect the new mechanism
The scientist of our country finds that resists hepatitis B and virus to infect the new mechanism
According to the report of Shanghai (Xinhua) the 3rd September ' Qiu Yi Sun Guo root) Through the untiring efforts of more than 4 years, Fudan University immuno-biology research institute rebukes and thinks of the scientific research group that the east professor headed in studying the B-mode hepatitis virus and infecting inherent immune mechanism of the human body, find TRIM22 molecule in the human body is of great importance in resisting the B-mode hepatitis virus to infect. Research results this issue in latest issue of internationally famous publications at " whether the intersection of liver and disease learn the magazine " already. The scientific research group verifies, TRIM22 molecule means great to inhibiting the B-mode hepatitis virus from duplicating, preventing hepatitis B from happening through the internal and external tests of body many times. Scientific research personnel further discover, TRIM22 molecule can obviously inhibit the B-mode hepatitis virus' core and start the son's activity, thus achieve and inhibit the purpose that the virus duplicates. The scientist discovers recently, generally have a TRIM22 molecule in the human body, but people do not understand its function and function. The research of group that Xiong SiDong leads shows, such new member is actually a kind of beneficial inherent immune member to human body. After some people are infected with hepatitis B and virus, can stimulate in the body rapidly inherent immunity and peculiar immune mechanism inhibit the virus from duplicating, remove hepatitis B and virus, thus fully recover, among them TRIM22 molecule has played an important role; And after another part of people are infected with hepatitis B and virus, cause hepatitis B and virus to infect because the internal TRIM22 molecule can not contribute effectively in right time, and will further develop into chronic hepatitis, even hepatocarcinoma. In addition, interferon is one of the effective medicines to treat the chronic hepatitis B at present, relevant to discover, interferon may be through stimulating TRIM22 molecule, inhibit hepatitis B and virus from duplicating. The research results have announced the human body resists the important inherent immune mechanism that hepatitis B and virus infect for the first time, continue researching and developing a new generation and having important meanings to infect medicines to resist hepatitis B and virus to scientific circles.


|